Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: an Open Label Pilot Study of Anticholinergic Agent vs. Mirabegron (MYRBETRIQ) to Evaluate Cognitive Impact and Efficacy
Latest Information Update: 30 Apr 2021
At a glance
- Drugs Mirabegron (Primary)
- Indications Neurogenic bladder; Spinal cord injuries
- Focus Therapeutic Use
- Acronyms SCIMYR
- 28 Apr 2021 Status changed from active, no longer recruiting to completed.
- 22 Dec 2020 Planned End Date changed from 1 Nov 2020 to 1 Mar 2021.
- 08 Jul 2020 Planned End Date changed from 30 Nov 2021 to 1 Nov 2020.